Published ResearchReduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 VariantAugust 6, 2024
Public HealthPreventable hospitalizations with increased oral SARS-CoV-2 antiviral treatmentFebruary 5, 2024
Public HealthProportion of Hospitalizations Preventable with Increased Oral SARS-CoV-2 Antiviral TreatmentDecember 21, 2023
Public HealthInsights from IDWeek 2023: Viral SARS-CoV-2 rebound in untreated and anti-viral treated patientsDecember 4, 2023
Presented ResearchPoster: Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claimsOctober 17, 2023
Public HealthTop Viral Surveillance Insights: XBB.1.5 is the new variant on the blockJanuary 13, 2023
Helix PartnersHelix & CDC Expand Partnership to Build First Ever Pan-Respiratory Viral Surveillance ProgramDecember 15, 2022